SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-047317
Filing Date
2017-02-17
Accepted
2017-02-17 07:02:11
Documents
107
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d474152d10k.htm 10-K 1171059
2 EX-10.45 d474152dex1045.htm EX-10.45 103542
3 EX-10.46 d474152dex1046.htm EX-10.46 113345
4 EX-21.1 d474152dex211.htm EX-21.1 2992
5 EX-23.1 d474152dex231.htm EX-23.1 1576
6 EX-31.1 d474152dex311.htm EX-31.1 9150
7 EX-31.2 d474152dex312.htm EX-31.2 8826
8 EX-32.1 d474152dex321.htm EX-32.1 4816
15 GRAPHIC g474152g36o43.jpg GRAPHIC 101900
  Complete submission text file 0001193125-17-047317.txt   7112262

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT vnda-20161231.xml EX-101.INS 1151611
10 XBRL TAXONOMY EXTENSION SCHEMA vnda-20161231.xsd EX-101.SCH 83239
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnda-20161231_cal.xml EX-101.CAL 108499
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnda-20161231_def.xml EX-101.DEF 484639
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnda-20161231_lab.xml EX-101.LAB 610941
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnda-20161231_pre.xml EX-101.PRE 577615
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 17619717
SIC: 2834 Pharmaceutical Preparations